Q4 2023 · 13F-HR
Bruce & Co., Inc.holdings as filed
Filed 2024-02-12 · accession 0001104659-24-014040
$286.6M
Reported value
37
Positions
2023-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 023586506 | UHAL/B | Uhaul B | $37.8M | 13.2% | 536,350 | Common | SOLE |
| 589331107 | — | Merck | $24.1M | 8.40% | 220,700 | Common | SOLE |
| 00287Y109 | ABBV | Abbvie | $21.4M | 7.46% | 138,000 | Common | SOLE |
| 26441C204 | DUK | Duke Energy | $19.8M | 6.90% | 203,890 | Common | SOLE |
| 98389B100 | XEL | XEL Energy | $18.4M | 6.42% | 293,000 | Common | SOLE |
| 125896100 | CMS | CMS Energy | $18.4M | 6.40% | 316,000 | Common | SOLE |
| 302571104 | — | Nextera Energy | $17.8M | 6.22% | 293,600 | Common | SOLE |
| 020002101 | ALL | Allstate | $17.8M | 6.21% | 127,200 | Common | SOLE |
| 002824100 | ABT | Abbott | $16.5M | 5.76% | 150,000 | Common | SOLE |
| 00206R102 | T | AT & T | $16.1M | 5.63% | 961,000 | Common | SOLE |
| 45774W108 | IIIN | Insteel | $13.1M | 4.59% | 343,423 | Common | SOLE |
| 717081103 | PFE | Pfizer | $7.7M | 2.70% | 268,500 | Common | SOLE |
| 05379B107 | AVA | Avista | $7.2M | 2.51% | 201,500 | Common | SOLE |
| 237266101 | DAR | Darling Ingredients | $7.0M | 2.43% | 140,000 | Common | SOLE |
| 037833100 | AAPL | Apple | $6.8M | 2.36% | 35,100 | Common | SOLE |
| 91911K102 | — | Bausch Health | $5.2M | 1.80% | 644,000 | Common | SOLE |
| 023586100 | UHAL | Uhaul | $5.1M | 1.77% | 70,805 | Common | SOLE |
| 82968B103 | SIRIEUR | XM Sirius | $3.1M | 1.06% | 557,843 | Common | SOLE |
| 268311107 | EDAP | EDAP | $2.9M | 1.02% | 553,652 | Common | SOLE |
| 651639106 | NEM | Newmont | $2.7M | 0.95% | 65,600 | Common | SOLE |
| 00484MAB2 | — | Acorda Theraputics | $2.4M | 0.85% | 5,000,000 | Common | SOLE |
| 868459108 | SUPN | Supernus | $2.4M | 0.83% | 82,105 | Common | SOLE |
| 00430HAC6 | — | Accelerate Diagnostic | $1.9M | 0.67% | 3,133,920 | Common | SOLE |
| 50015M109 | KOD | Kodiak Sciences | $1.4M | 0.50% | 473,000 | Common | SOLE |
| 925815102 | VICR | Vicor | $1.3M | 0.47% | 30,000 | Common | SOLE |
| 044209104 | — | Ashland | $1.3M | 0.44% | 15,000 | Common | SOLE |
| N51517105 | 4PKB | Lava Theraputics | $1.2M | 0.43% | 771,874 | Common | SOLE |
| 142038108 | CRBU | Caribu Biosciences | $1.1M | 0.40% | 200,000 | Common | SOLE |
| 65443P102 | MASS | 908 Devices | $766,169 | 0.27% | 68,286 | Common | SOLE |
| 56400P706 | MNKD | Mannkind | $710,066 | 0.25% | 195,073 | Common | SOLE |
| 92556V106 | VTRS | Viatris | $630,869 | 0.22% | 58,252 | Common | SOLE |
| 71535D106 | PSNL | Personalis | $630,000 | 0.22% | 300,000 | Common | SOLE |
| 449585108 | 1K0 | IGM Bioscience | $540,150 | 0.19% | 65,000 | Common | SOLE |
| 31189P102 | FATE | Fate Theraputics | $534,820 | 0.19% | 143,000 | Common | SOLE |
| 68622V106 | OGN | Organon | $449,760 | 0.16% | 31,190 | Common | SOLE |
| 749607107 | RLI | RLI | $266,240 | 0.09% | 2,000 | Common | SOLE |
| 934423104 | WBD | Warner Bros. Discovery | $121,106 | 0.04% | 10,642 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.